FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2407221319> ?p ?o ?g. }

• W2407221319 endingPage "1055" @default.
• W2407221319 startingPage "1047" @default.
• W2407221319 abstract "A recent study investigated the role of testosterone (T) in chronic prostatitis or chronic pelvic pain syndrome (CP/CPPS). However, only a small amount of data is available to date, and the results are inconsistent.To evaluate the relation between total T (TT) and CP/CPPS.We conducted a propensity-matched study by identifying men with a TT level lower than 3.5 ng/mL among 8,336 men in their 40s and 50s. A control group of men with a TT level of at least 3.5 ng/mL matched for age, metabolic syndrome, and body mass index at a 5:1 ratio was selected for comparison. Using the same cohort and methods, another case group (TT < 3.0 ng/mL) and control group (TT ≥ 3.0 ng/mL) were selected. The National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) was administered. A χ(2) test, a t-test and logistic regression analyses were used to evaluate the relation between TT and prostatitis-like symptoms.Association of TT with NIH-CPSI score.After propensity score matching, 948 cases (TT < 3.5 ng/mL) and 4,740 controls (TT ≥ 3.5 ng/mL) were included. The ratio of mild and moderate to severe prostatitis-like symptoms was higher in the case group than in the control group (24.0% vs 27.4%, P = .001). The ratio of moderate to severe prostatitis-like symptoms also was higher in the case group than in the control group (6.2% vs 9.2%, P = .028). The pain domain of the NIH-CPSI, quality of life, and total NIH-CPSI scores also were higher in the case group. Ratios of severe lower urinary tract symptoms (12.6% vs 15.1%, P = .044) to maximal flow rate no higher than 10 mL/sec (3.8% vs 5.3%, P = .044) and postvoid residual urine volume of at least 100 mL (4.0% vs 5.6%, P = .035), which suggest high pressure in the prostate urethra, were higher in the case group. After adjusting for voided volume during uroflowmetry and total prostate volume, the relations of a TT level lower than 3.5 ng/mL to a maximal flow rate no higher than 10 mL/sec (odds ratio = 1.402, 95% CI = 1.017-1.934, P = .039) and to a postvoid residual urine volume of at least 100 mL (odds ratio = 1.410, 95% CI = 1.031-1.927, P = .031) were maintained. Using the cutoff TT value of 3.0 ng/mL, 437 cases (TT < 3.0 ng/mL) and 2,185 controls (TT ≥ 3.0 ng/mL) were included. The result of the 3.0-ng/mL cutoff value for TT showed a higher incidence of prostatitis-like symptoms in the group with a TT level lower than 3.0 ng/mL, but this was not statistically significant.Low TT level (<3.5 ng/mL) was significantly correlated with prostatitis-like symptoms in this study." @default.
• W2407221319 created "2016-06-24" @default.
• W2407221319 creator A5030248447 @default.
• W2407221319 creator A5044912860 @default.
• W2407221319 date "2016-07-01" @default.
• W2407221319 modified "2023-09-30" @default.
• W2407221319 title "Testosterone and Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Propensity Score-Matched Analysis" @default.
• W2407221319 cites W1504137925 @default.
• W2407221319 cites W1945364840 @default.
• W2407221319 cites W1965009753 @default.
• W2407221319 cites W1978104042 @default.
• W2407221319 cites W1982292666 @default.
• W2407221319 cites W1985576983 @default.
• W2407221319 cites W1986245915 @default.
• W2407221319 cites W1988006586 @default.
• W2407221319 cites W1997517088 @default.
• W2407221319 cites W1999265976 @default.
• W2407221319 cites W2009913352 @default.
• W2407221319 cites W2020670424 @default.
• W2407221319 cites W2031394281 @default.
• W2407221319 cites W2032560652 @default.
• W2407221319 cites W2033902997 @default.
• W2407221319 cites W2037711032 @default.
• W2407221319 cites W2060544088 @default.
• W2407221319 cites W2066024733 @default.
• W2407221319 cites W2066862281 @default.
• W2407221319 cites W2078606580 @default.
• W2407221319 cites W2079558648 @default.
• W2407221319 cites W2094969891 @default.
• W2407221319 cites W2096237552 @default.
• W2407221319 cites W2103714496 @default.
• W2407221319 cites W2110130030 @default.
• W2407221319 cites W2111078766 @default.
• W2407221319 cites W2113473370 @default.
• W2407221319 cites W2118350191 @default.
• W2407221319 cites W2123593174 @default.
• W2407221319 cites W2124998345 @default.
• W2407221319 cites W2140244441 @default.
• W2407221319 cites W2143505183 @default.
• W2407221319 cites W2144597464 @default.
• W2407221319 cites W2152849583 @default.
• W2407221319 cites W2154765924 @default.
• W2407221319 cites W2155003679 @default.
• W2407221319 cites W2161784024 @default.
• W2407221319 cites W2169593157 @default.
• W2407221319 doi "https://doi.org/10.1016/j.jsxm.2016.04.070" @default.
• W2407221319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27235281" @default.
• W2407221319 hasPublicationYear "2016" @default.
• W2407221319 type Work @default.
• W2407221319 sameAs 2407221319 @default.
• W2407221319 citedByCount "15" @default.
• W2407221319 countsByYear W24072213192017 @default.
• W2407221319 countsByYear W24072213192018 @default.
• W2407221319 countsByYear W24072213192020 @default.
• W2407221319 countsByYear W24072213192021 @default.
• W2407221319 countsByYear W24072213192022 @default.
• W2407221319 countsByYear W24072213192023 @default.
• W2407221319 crossrefType "journal-article" @default.
• W2407221319 hasAuthorship W2407221319A5030248447 @default.
• W2407221319 hasAuthorship W2407221319A5044912860 @default.
• W2407221319 hasConcept C121608353 @default.
• W2407221319 hasConcept C126322002 @default.
• W2407221319 hasConcept C141071460 @default.
• W2407221319 hasConcept C146304588 @default.
• W2407221319 hasConcept C151956035 @default.
• W2407221319 hasConcept C17923572 @default.
• W2407221319 hasConcept C2776235491 @default.
• W2407221319 hasConcept C2776362571 @default.
• W2407221319 hasConcept C2779279991 @default.
• W2407221319 hasConcept C2780136519 @default.
• W2407221319 hasConcept C2780221984 @default.
• W2407221319 hasConcept C2780524745 @default.
• W2407221319 hasConcept C71924100 @default.
• W2407221319 hasConcept C90924648 @default.
• W2407221319 hasConceptScore W2407221319C121608353 @default.
• W2407221319 hasConceptScore W2407221319C126322002 @default.
• W2407221319 hasConceptScore W2407221319C141071460 @default.
• W2407221319 hasConceptScore W2407221319C146304588 @default.
• W2407221319 hasConceptScore W2407221319C151956035 @default.
• W2407221319 hasConceptScore W2407221319C17923572 @default.
• W2407221319 hasConceptScore W2407221319C2776235491 @default.
• W2407221319 hasConceptScore W2407221319C2776362571 @default.
• W2407221319 hasConceptScore W2407221319C2779279991 @default.
• W2407221319 hasConceptScore W2407221319C2780136519 @default.
• W2407221319 hasConceptScore W2407221319C2780221984 @default.
• W2407221319 hasConceptScore W2407221319C2780524745 @default.
• W2407221319 hasConceptScore W2407221319C71924100 @default.
• W2407221319 hasConceptScore W2407221319C90924648 @default.
• W2407221319 hasIssue "7" @default.
• W2407221319 hasLocation W24072213191 @default.
• W2407221319 hasLocation W24072213192 @default.
• W2407221319 hasOpenAccess W2407221319 @default.
• W2407221319 hasPrimaryLocation W24072213191 @default.
• W2407221319 hasRelatedWork W1981765034 @default.
• W2407221319 hasRelatedWork W2038464024 @default.
• W2407221319 hasRelatedWork W2329658345 @default.
• W2407221319 hasRelatedWork W2790358997 @default.
• W2407221319 hasRelatedWork W2941954413 @default.

• next